207 related articles for article (PubMed ID: 26882230)
1. Metabolic Syndrome in South African Patients with Severe Mental Illness: Prevalence and Associated Risk Factors.
Saloojee S; Burns JK; Motala AA
PLoS One; 2016; 11(2):e0149209. PubMed ID: 26882230
[TBL] [Abstract][Full Text] [Related]
2. Very low rates of screening for metabolic syndrome among patients with severe mental illness in Durban, South Africa.
Saloojee S; Burns JK; Motala AA
BMC Psychiatry; 2014 Aug; 14():228. PubMed ID: 25113131
[TBL] [Abstract][Full Text] [Related]
3. Prevalence and Associated Factors of Metabolic Syndrome among Patients with Severe Mental Illness Attending a Tertiary Hospital in Southwest Uganda.
Agaba DC; Migisha R; Namayanja R; Katamba G; Lugobe HM; Aheisibwe H; Twesigomwe G; Ashaba S
Biomed Res Int; 2019; 2019():1096201. PubMed ID: 31815121
[TBL] [Abstract][Full Text] [Related]
4. Metabolic syndrome in antipsychotic naive African patients with severe mental illness in usual care.
Saloojee S; Burns JK; Motala AA
Early Interv Psychiatry; 2018 Dec; 12(6):1137-1143. PubMed ID: 28402033
[TBL] [Abstract][Full Text] [Related]
5. High risk of metabolic syndrome among black South African women with severe mental illness.
Saloojee S; Burns JK; Motala AA
S Afr J Psychiatr; 2017; 23():1089. PubMed ID: 30263202
[TBL] [Abstract][Full Text] [Related]
6. Prevalence of metabolic syndrome and its associated risk factors in an African-Caribbean population with severe mental illness.
de Caluwé L; van Buitenen N; Gelan PJ; Crunelle CL; Thomas R; Casseres S; Matthys F; van Harten P; Cahn W
Psychiatry Res; 2019 Nov; 281():112558. PubMed ID: 31546147
[TBL] [Abstract][Full Text] [Related]
7. The prevalence of metabolic syndrome in patients receiving antipsychotics in Qatar: a cross sectional comparative study.
Hammoudeh S; Ghuloum S; Mahfoud Z; Yehya A; Abdulhakam A; Al-Mujalli A; Al-Zirie M; Abdel Rahman MO; Godwin A; Younes N; Hani Y; Mook-Kanamori D; Mook-Kanamori M; El Sherbiny R; Al-Amin H
BMC Psychiatry; 2018 Mar; 18(1):81. PubMed ID: 29587717
[TBL] [Abstract][Full Text] [Related]
8. The prevalence of metabolic syndrome in people with severe mental illness: a mediation analysis.
Carrà G; Bartoli F; Carretta D; Crocamo C; Bozzetti A; Clerici M; Bebbington PE
Soc Psychiatry Psychiatr Epidemiol; 2014 Nov; 49(11):1739-46. PubMed ID: 24562318
[TBL] [Abstract][Full Text] [Related]
9. Prevalence and predictors of metabolic syndrome in patients with schizophrenia and healthy controls: A study in rural South Indian population.
Rawat VS; Ganesh S; Bijjal S; Shanivaram Reddy K; Agarwal V; Devi R; Kumar CN; Christopher R; Thirthalli J
Schizophr Res; 2018 Feb; 192():102-107. PubMed ID: 28454923
[TBL] [Abstract][Full Text] [Related]
10. Ethnic disparities in the prevalence of metabolic syndrome and its risk factors in the Suriname Health Study: a cross-sectional population study.
Krishnadath IS; Toelsie JR; Hofman A; Jaddoe VW
BMJ Open; 2016 Dec; 6(12):e013183. PubMed ID: 27927663
[TBL] [Abstract][Full Text] [Related]
11. Metabolic Syndrome and Cardiovascular Risk in People Treated with Long-Acting Injectable Antipsychotics.
Sanchez-Martinez V; Romero-Rubio D; Abad-Perez MJ; Descalzo-Cabades MA; Alonso-Gutierrez S; Salazar-Fraile J; Montagud V; Facila L
Endocr Metab Immune Disord Drug Targets; 2018; 18(4):379-387. PubMed ID: 29165095
[TBL] [Abstract][Full Text] [Related]
12. The effect of ziprasidone on metabolic syndrome risk factors in subjects with schizophrenia: a 1 year, open-label, prospective study.
Chue P; Mandel FS; Therrien F
Curr Med Res Opin; 2014 Jun; 30(6):997-1005. PubMed ID: 24568177
[TBL] [Abstract][Full Text] [Related]
13. Metabolic syndrome and its predictors in an urban population in Kenya: A cross sectional study.
Omuse G; Maina D; Hoffman M; Mwangi J; Wambua C; Kagotho E; Amayo A; Ojwang P; Premji Z; Ichihara K; Erasmus R
BMC Endocr Disord; 2017 Jul; 17(1):37. PubMed ID: 28676116
[TBL] [Abstract][Full Text] [Related]
14. Prevalence of the metabolic syndrome in Danish psychiatric outpatients treated with antipsychotics.
Krane-Gartiser K; Breum L; Glümrr C; Linneberg A; Madsen M; Køster A; Jepsen PW; Fink-Jensen A
Nord J Psychiatry; 2011 Oct; 65(5):345-52. PubMed ID: 21428861
[TBL] [Abstract][Full Text] [Related]
15. Screening and prevalence of cardiometabolic risk factors in patients with severe mental illness: A multicenter cross-sectional cohort study in the Netherlands.
Noortman L; de Winter L; van Voorst A; Cahn W; Deenik J
Compr Psychiatry; 2023 Oct; 126():152406. PubMed ID: 37506537
[TBL] [Abstract][Full Text] [Related]
16. Association between metabolic syndrome and 10-year risk of developing cardiovascular disease in a Nigerian population.
Oguoma VM; Nwose EU; Skinner TC; Richards RS; Digban KA; Onyia IC
Int Health; 2016 Sep; 8(5):354-9. PubMed ID: 27118483
[TBL] [Abstract][Full Text] [Related]
17. Assessment of cardiovascular risk in an Italian psychiatric outpatient sample: A chart review of patients treated with second-generation antipsychotics.
Severi E; Ferrara M; Tedeschini E; Vacca F; Mungai F; Amendolara R; Baccari F; Starace F
Int J Ment Health Nurs; 2018 Jun; 27(3):1002-1008. PubMed ID: 29197134
[TBL] [Abstract][Full Text] [Related]
18. [Drawing up guidelines for the attendance of physical health of patients with severe mental illness].
Saravane D; Feve B; Frances Y; Corruble E; Lancon C; Chanson P; Maison P; Terra JL; Azorin JM;
Encephale; 2009 Sep; 35(4):330-9. PubMed ID: 19748369
[TBL] [Abstract][Full Text] [Related]
19. Monitoring and prevalence rates of metabolic syndrome in military veterans with serious mental illness.
Khatana SA; Kane J; Taveira TH; Bauer MS; Wu WC
PLoS One; 2011 Apr; 6(4):e19298. PubMed ID: 21541294
[TBL] [Abstract][Full Text] [Related]
20. Metabolic syndrome, glucose tolerance categories and the cardiovascular risk in Spanish population.
Martínez-Larrad MT; Corbatón-Anchuelo A; Fernández-Pérez C; Lazcano-Redondo Y; Escobar-Jiménez F; Serrano-Ríos M
Diabetes Res Clin Pract; 2016 Apr; 114():23-31. PubMed ID: 27103365
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
